See for the latest information about COVID-19 vaccinations in Canterbury.
View our COVID-19 page for general advice, where to get COVID-19 tests, and visiting guidelines for our hospital services.

Autologous haematopoietic stem cell transplants (aHSCT) available to patients

Summary of official information request

Multiple Sclerosis New Zealand is aware that your DHB has been presented with a Business Case to make autologous haematopoietic stem cell transplants (aHSCT) available in your DHB to patients with Multiple Sclerosis. Multiple Sclerosis New Zealand requests a copy of this Business Case along with further information including any analysis of the business case correspondence etc regarding your decisions on this application.


Download (pdf, 100KB)

Back to Document Library

Page last updated: 23 June 2021

Is this page useful?